欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
VcMMAE_646502-53-6_产品详情
646502-53-6
  • names:

    VcMMAE

  • CAS号:

    646502-53-6

    MDL Number:
  • MF(分子式): C68H105N11O15 MW(分子量): 1316.63
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
VcMMAE
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001054-5mg 5mg 99.89% ¥ 6075.00 ¥ 6075.00 2-3天
- +
¥ 0.00
YZM001054-1mg 1mg 99.89% ¥ 2145.00 ¥ 2145.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 646502-53-6
Inchi
InchiKey
分子式 Formula C68H105N11O15
分子量 Molecular Weight 1316.63
溶解度Solubility 生物体外In Vitro:DMSO溶解度≥ 54 mg/mL(41.01 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知.
性状
储藏条件 Storage conditions 4°C, In solvent : -80°C, 6月; -20°C, 1月 (protect from light, stored under nitrogen)
VcMMAE(CAS:646502-53-6)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 VcMMAE (mc-vc-PAB-MMAE) 为抗体药物复合体的一部分 (drug-linker conjugate for ADC),具有抗癌活性,它由 MMAE (一种 tubulin 抑制剂) 和 Vc 连接而成
IntroductionVcMMAE (mccABMAE) is adruginker conjugate for ADCwith potent antitumor activity by using the antiitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the lysosomally cleavable dipeptide, valineitrulline (vc).
Application1
Application2
Application3
VcMMAE (mc-vc-PAB-MMAE) 为抗体药物复合体的一部分 (drug-linker conjugate for ADC),具有抗癌活性,它由 MMAE (一种 tubulin 抑制剂) 和 Vc 连接而成。VcMMAE (mc-vc-PAB-MMAE) is adrug-linker conjugate for ADCwith potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the lysosomally cleavable dipeptide, valine-citrulline (vc).
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Okeley, et al. Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate. Clinical Cancer Research (2010), 16(3), 888-897.
【2】.Lisa Buckel, et al. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery. Cancer Res. 2015 Apr 1;75(7):1376-87.
【3】.Jianmin Fang, et al. Anti-her2 antibody and conjugate thereof. US 20160304621 A1.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents